Omental band induced bowel ischemia following combination immunotherapy in a patient with renal cell cancer.

The Role of APOL1 in Necrotizing Enterocolitis and Its Promise as a Diagnostic Biomarker.

Guselkumab: Pediatric First Approval.

Etrasimod: A Next-Generation S1P Receptor Modulator for Ulcerative Colitis - Mechanistic Insights and Clinical Progress.

Ovarian T-cell lymphoma in a dog with chronic protein-losing enteropathy.

Gut Microbiota as Neuroimmune Modulators in Myasthenia Gravis: Mechanistic Insights from the Gut-Brain Axis to Therapeutic Innovations.

Inhibiting METTL3 in macrophages alleviates colitis by enhancing M2 polarization via upregulating IRAKM.

Multi-omics analyses reveal the pathogenic role of terminal ileum-derived IgA+β7+ cells in IgA nephropathy.

Impact of a GABA-Producing Lactococcus lactis on Microbiota and Mycobiota During CNS Inflammatory Demyelination.

Targeting MLCK1 uncouples immune checkpoint inhibitor-induced colitis from antitumour immunity.

Therapeutic Modulation of IL-6/STAT-3 and Nitric Oxide by Fenofibrate in Patients With Ulcerative Colitis: A Randomized Controlled Pilot Study.

[Upper-gastrointestinal tract toxicities associated with Immune Checkpoint Inhibitors (ICI)].

Large-scale multi-trait genome-wide analysis for inflammatory bowel disease reveals new insights into its molecular mechanisms and emphasizes the roles of systemic immune regulation.

Hepatic Steatosis and Diet in Adult Celiac Disease: A Cross-Sectional Study.

Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations.

Association of IL12RB2, RORC, and class II HLA polymorphisms with severe erythema multiforme of regorafenib in Japanese patients with colorectal cancer.

Colon chaos: when drugs turn against your gut.

A myeloid Tet2-IL-1β axis modulates intestinal inflammation by restricting catecholaminergic stimulation of enterochromaffin cell differentiation.

Apremilast as a novel therapeutic option for psoriasis coexisting primary sclerosing cholangitis and ulcerative colitis: A case report.

Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study.

Impact of GLP-1 analogues on immune-mediated inflammatory diseases: A systematic review.

Asthma remission in the context of other immune-mediated diseases.

Autoimmune enteropathy in an infant, a rare entity possibly triggered in utero.

Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis.

Appendiceal B lymphocytes contribute to the pathogenesis of experimental colitis through fueling colonic CD4+ T polarization.

Fatigue in patients with inflammatory bowel disease: A descriptive cross-sectional study.

Combination therapy with biologics and/or small molecules in inflammatory bowel disease: a comprehensive review.

Palmitic Acid Esterification Boosts Epigallocatechin Gallate's Immunomodulatory Effects in Intestinal Inflammation.

Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease.

Protective and therapeutic potentials of Trichinella spiralis larval antigen in murine induced colitis.

Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis.

Bank1 deficiency reshapes the gut microbiota of lupus mice towards an anti-inflammatory composition.

Practical considerations for the use of IL-23p19 inhibitors in inflammatory bowel disease: how to choose between them and why it matters?

Evaluation of the systemic immune-inflammation index in relation to histological stages of celiac disease.

IMMUNE DYSREGULATION AND EPITHELIAL STRESS IN CELIAC DISEASE PROGRESSION: A FOCUS ON REFRACTORY CELIAC DISEASE SUBTYPES.

Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review.

Artificial intelligence in inflammatory bowel disease endoscopy - a review of current evidence and a critical perspective on future challenges.

The Impact of Fecal Diversion on Immune Checkpoint Inhibitor Adverse Gastrointestinal Toxicities.

Relieving the discrimination dilemma of adult autoimmune enteropathy and common variable immunodeficiency disease: two rare causes of chronic diarrhea and small intestinal villous atrophy.

Diagnostic Challenges in Enteropathies: A Histopathological Review.

Janus Kinase Inhibitor-Induced Acne in Inflammatory Bowel Disease: An International, Multicenter, Retrospective Cohort Study.

Sphingosine-1-Phosphate Receptor Modulators for the Treatment of Ulcerative Colitis: A Narrative Review Focusing on Safety.

Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free diet.

Latent class analysis identifies novel coeliac disease subgroups with distinctive clinical features: a multicentric study.

Oral Peptide Therapeutics as an Emerging Treatment Modality in Immune-Mediated Inflammatory Diseases: A Narrative Review.

Diagnostic Yield of Video Capsule Endoscopy (VCE) in Celiac Disease (CD): A Systematic Review and Meta-analysis.

Hypoalbuminemia and Generalized Edema as the Presenting Symptoms of Celiac Disease in a Two-Year-Old Girl: A Case Report.

Serum C-Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Cross-Sectional Cohort Study.

Autoantibody Profiling in Ulcerative Colitis: Identification of Early Immune Signatures and Disease-Associated Antigens for Improved Diagnosis and Monitoring.

Mild Duodenal Mucosal Injury and Increased Type I Interferon Signaling Are Preludes to Celiac Disease.

Assessment of Intestinal Free Fatty Acid Binding Protein 4 in Alopecia Areata Patients.

A Rare Association of Celiac Disease and Aplastic Anemia.

The role of microbial succinate in the pathophysiology of inflammatory bowel disease: mechanisms and therapeutic potential.

Tas2r105 ameliorates gut inflammation, possibly through influencing the gut microbiota and metabolites.

Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety Analysis.

Differential Disease Behavior of Immune-Mediated Colitis Among Different Types of Immune Checkpoint Inhibition.

The Impact of Concomitant Hypothyroid Disease on the Course of Inflammatory Bowel Disease.

Evaluation of fecal neutrophil gelatinase-associated lipocalin levels in childhood inflammatory bowel disease.

Effects of a Gluten-Free Diet on Brain Bioelectrical Activity and Neurological Symptoms in Children with Celiac Disease: A Study Using EEG Assessment.

Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1.

Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3.

Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE).

Advances and challenges in diagnosing and managing adult autoimmune enteropathy.

Ubiquitination of TFEB increased intestinal permeability to aggravate metabolic dysfunction-associated steatohepatitis.

The TL1A inhibitors in IBD: what's in the pot?

A Similar Mutation in the AAUU-Rich Elements of the Mouse TNF Gene Results in a Distinct Ileocolitic Phenotype: A New Strain of TNF-Overexpressing Mice.

Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responses.

Presence of Pseudomonas aeruginosa in feces exacerbate leaky gut in mice with low dose dextran sulfate solution, impacts of specific bacteria.

Cow's milk protein allergy in infants and children.

Development of interleukin-27 recombinant Lactococcus lactis and its efficacy in treating psoriasis and colitis in mice.

Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.

Update on the Epidemiology and Management of Microscopic Colitis.

Adult-Onset Autoimmune Enteropathy Mimicking Disaccharidase Deficiency.

Fulminant immune-related colitis after dual checkpoint inhibitor therapy: case report.

Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning.

Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases.

Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases.

The emerging role of oxidative stress in inflammatory bowel disease.

Serum calgranulin C as a non-invasive predictor of activity among inflammatory bowel disease.

Impact of Cigarette Smoking on Clinical Presentation and Treatment Response in Coeliac Disease.

COVID-19 IN INFLAMMATORY BOWEL DISEASE: SHOULD WE BE MORE CAREFUL WITH THE USE OF SALICYLATES?

Dopamine β-hydroxylase shapes intestinal inflammation through modulating T cell activation.

Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies.

Oral small molecule agents in management of ulcerative colitis: fact or fancy?

Trichinella spiralis alleviates LPS-induced acute lung injury by modulating the protective Th2 immune response.

Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study.

Combination treatment of inflammatory bowel disease: Present status and future perspectives.

Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases?

Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.

Serum Amyloid A as a non-invasive predictive biomarker of mucosal healing in ulcerative colitis patients.

Disruption of post-thymic tolerance in skin-reactive TCR transgenic mice through the interaction of lymphopenia and intestinal microbiota.

In major dysmood disorder, physiosomatic, chronic fatigue and fibromyalgia symptoms are driven by immune activation and increased immune-associated neurotoxicity.

Colitis due to cancer treatment with immune check-point inhibitors - review of literature and presentation of clinical cases.

Upadacitinib in Crohn's disease.

Immune-mediated diseases are associated with a higher risk of ALS incidence: a prospective cohort study from the UK Biobank.

Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis.

Celiac Disease-Related Conditions: Who to Test?

Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models.

Etrasimod: First Approval.

mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses.

The Conjunctival Microbiome and Dry Eye: What We Know and Controversies.

Primary clostridium difficile infection in patients with ulcerative colitis: Case report and literature review.

Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients.

Short-chain fatty acids ameliorate experimental anti-glomerular basement membrane disease.

Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis.

Cutaneous Disorders Masking Celiac Disease: Case Report and Mini Review with Proposal for a Practical Clinical Approach.

Vitamin D Levels as a Potential Modifier of Eosinophilic Esophagitis Severity in Adults.

Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data.

Role of ustekinumab in treatment of ulcerative colitis: a narrative review.

Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn's Disease.

Nephropathy Is Aggravated by Fatty Acids in Diabetic Kidney Disease through Tubular Epithelial Cell Necroptosis and Is Alleviated by an RIPK-1 Inhibitor.

Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A Case Report and Review of the Literature.

Unraveling the Immunopathological Landscape of Celiac Disease: A Comprehensive Review.

Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in CTLA4 gene: A case report.

Immune-mediated colitis associated with ocrelizumab: A new safety risk.

Suprabasal cells retain progenitor cell identity programs in eosinophilic esophagitis-driven basal cell hyperplasia.

A longitudinal study of distress symptoms and work impairment in immune-mediated inflammatory diseases.

Cross-sectional imaging: current status and future potential in adult celiac disease.

The importance of predicting patient responses to monoclonal antibodies for Crohn's disease.

An update on the safety of long-term vedolizumab use in inflammatory bowel disease.

Celiac Disease Masquerading as Extreme Thrombocytosis and Severe Anemia in a 52-Year-Old Female Patient: A Rare Case Presentation and Literature Review.

Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.

Amelioration of DSS-induced colitis in mice by TNF-α-stimulated mesenchymal stem cells derived from feline adipose tissue via COX-2/PGE2 activation.

Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, A By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis.

Topotecan alleviates acetic acid-induced ulcerative colitis in rats via attenuation of the RORγT transcription factor.

Prevention of colitis-induced liver oxidative stress and inflammation in a transgenic mouse model with increased omega-3 polyunsaturated fatty acids.

Glucocorticoid effects in the regenerating fin reflect tissue homeostasis disturbances in zebrafish by affecting Wnt signaling.

Gastrointestinal involvement of passenger lymphocyte syndrome followed by minor ABO-incompatible renal transplantation: A case report.

A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review.

Celiac Disease in Children: A 2023 Update.

Targeting IL-23 for IBD: Rationale and Progress to Date.

Functional assays to evaluate antibody-mediated responses against Shigella: a review.

Celiac crisis as the life-threatening onset of celiac disease in children: a case report.

Extensive ischaemic colitis-like colonic lesions in eosinophilic granulomatosis with polyangiitis.

Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options.

The evaluation of liver abnormalities in inflammatory bowel disease patients.

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus.

Celiac Disease Is a Risk Factor for Mature T and NK Cell Lymphoma: A Mendelian Randomization Study.

Peripheral blood T-lymphocyte subsets are potential biomarkers of disease severity and clinical outcomes in patients with ulcerative colitis: a retrospective study.

Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors.

Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs.

Intestinal barrier dysfunction as a key driver of severe COVID-19.

SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).

SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).

Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib.

Perspectives on Non-IgE-Mediated Gastrointestinal Food Allergy in Pediatrics: A Review of Current Evidence and Guidelines.

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.

Analysis of Alterations of the Gut Microbiota in Moderate to Severe Psoriasis Patients Using 16S rRNA Gene Sequencing.

MIF Variant rs755622 Is Associated with Severe Crohn's Disease and Better Response to Anti-TNF Adalimumab Therapy.

Etrasimod for the treatment of ulcerative colitis.

Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported Outcomes.

Molecular Imaging in Inflammatory Bowel Disease.

Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP.

Cyclosporine treatment for severe steroid refractory immune-mediated colitis in a patient with ulcerative colitis.

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.

The composition and function profile of the gut microbiota of patients with primary Sjögren's syndrome.

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities.

Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis.

A Review of Ophthalmic Complications in Inflammatory Bowel Diseases.

Treat-to-target and sequencing therapies in Crohn's disease.

Deucravacitinib: First Approval.

Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies.

Cross talk between the gut microbiome and host immune response in ulcerative colitis: nonpharmacological strategies to improve homeostasis.

Why targeted therapeutics have provided benefit in psoriasis: looking at IL-17 biology.

[Update on the Treatment of Inflammatory Bowel Disease].

Population Pharmacokinetics and Exposure-Response Analyses of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease.

Clinical Features and Outcomes of Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease and Spondyloarthropathies.

Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis.

Eosinophilic oesophagitis in Denmark: Population-based incidence and prevalence in a nationwide study from 2008 to 2018.

Concomitant Guillain-Barré Syndrome in a young Sri Lankan male with severe ulcerative colitis.

Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.

Subtyping of Eosinophilic Esophagitis Based on Disease Presentation in a pediatric Cohort.

[Celiac crisis and acute tetany in pediatrics. Case report].

Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic.

Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.

Systemic calcinosis in a Quarter Horse gelding homozygous for a myosin heavy chain 1 mutation.

Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment.

Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function.

Tacrolimus-binding protein FKBP8 directs myosin light chain kinase-dependent barrier regulation and is a potential therapeutic target in Crohn's disease.

The association between intestinal microbiome and autoimmune uveitis.

GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis in the treatment of inflammatory bowel disease.

Exacerbation of non-steroidal anti-inflammatory drug-induced enteropathy in C-C chemokine receptor type 7-deficient mice.

Review article: paradoxical psoriasis as a consequence of tumour necrosis factor antagonists in patients with inflammatory bowel disease.

Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.

A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach.

SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.

Gut Microbiome and Organ Fibrosis.

[Management of persistent colitis after successful immunotherapy for non-small cell carcinoma of the lung].

Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022?

Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination.

Concomitant Congenital Diaphagmatic Hernia (CDH) and bilateral bacterial glomerulonephritis in a pet chinchilla (Chinchilla lanigera).

Pediatric autoimmune disorders with gastrointestinal expressions: from bench to bedside.

Update on Food protein-induced enterocolitis syndrome (FPIES).

Remote regulation of type 2 immunity by intestinal parasites.

A Manifestation of Ulcerative Colitis During Treatment for Severe Plaque Psoriasis with Ixekizumab - A Report of Two Cases and Review of the Literature.

Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.

Novel Presentation of Terminal Ileitis Associated with Secukinumab Therapy.

Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism.

Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.

KIR3DS1 directs NK cell-mediated protection against human adenovirus infections.